After Hours Most Active for Dec 29, 2025 : LINE, GENI, NVDA, FUN, CMCSA, PFE, CSCO, PEP, OPEN, O, XOM, KBR

The NASDAQ 100 After Hours Indicator sits at 25,521.99, down 3.57, with total after-hours volume of 89,566,039 shares. The most active after-hours names include LINE (34.34, 4.14M shares; last sale 85.85% of $40 target), GENI (10.74, 4.11M; Zacks mean recommendation: buy), NVDA (188.04, 3.71M; Zacks: buy), FUN (15.33, 3.50M; Zacks: buy), CMCSA (29.68, 2.83M; 86.03% of $34.5 target), PFE (24.99, 2.52M; 90.87% of $27.5 target), CSCO (77.79, 2.41M; Zacks: buy), and OPEN (5.77, 2.22M; last sale 412.16% of $1.4 target). Exxon Mobil is quoted at 120.59 (+0.06, 1.39M) with three upward EPS revisions for the Dec-2025 quarter and a consensus EPS of $1.63; several stocks also display proximity to analyst target prices noted in the report.

Analysis

Market structure: After-hours activity (~89.6M shares) concentrates liquidity in large-cap tech (NVDA, CSCO), media (CMCSA) and energy (XOM). Winners are AI-exposed NVDA and oil-related XOM (XOM has 3 up EPS revisions and $1.63 consensus for Dec 2025), losers are mid/low-conviction names trading near target (CMCSA, PEP at ~88% of target) where upside is capped. Elevated after-hours flow signals short-term price discovery driven by algo/positioning rather than fresh fundamental revisions.

Risk assessment: Tail risks include a chip demand slowdown or regulatory action against dominant AI suppliers (NVDA) and an oil demand shock (OPEC cut reversal) that could flip XOM sentiment; probability low but impact large. Immediate (0–7 days) risks are earnings/macro prints and gamma pinning; short-term (1–3 months) risks are index rebalances and analyst downgrades; long-term (≥3 quarters) hinges on secular AI capex for NVDA and housing/fintech cycles for OPEN. Hidden dependency: ETF/quant flows into NASDAQ 100 amplify moves and can create crowded exits.

Trade implications: Prefer asymmetric option structures: modest long NVDA via 30–45 day call spreads sized 1–2% portfolio to capture pre-earnings upside while capping vega (target +10–20%, cut at -50% premium loss). Add 2–3% long XOM (or 3-month bull-call spread to $135 strike) to ride EPS upgrades. Implement a relative pair: long CSCO (2%) vs short CMCSA (1.5%) for 1–3 months given valuation/target gap. Speculative 0.5% long OPEN via deep-OTM 12–18 month calls (high risk/high reward).

Contrarian angles: Consensus underestimates systemic gamma and ETF-induced pressure — NVDA crowding can produce violent mean-reversion; OPEN’s price >> target suggests either a short-squeeze or analyst lag, not pure fundamental upside. Reaction to near-target stocks (PEP, CMCSA) appears pricing-in of analysts; overstretched positioning in NVDA/XOM could be vulnerable to macro data (CPI, payrolls) within 2–6 weeks, creating tactical re-entry points.

Key Decisions for Investors

• Establish a 1–2% portfolio position in NVDA using a 30–45 day 195/220 call spread (buy 195 call, sell 220 call) ahead of next earnings/AI catalysts; target a 10–20% profit or cut if premium falls 50%.
• Add a 2–3% bullish allocation to XOM via a 3-month bull-call spread (buy 120 call, sell 140 call) to capture upside from recent EPS revisions; set stop-loss at -30% of premium or if consensus EPS is revised down by >10%.
• Execute a pair trade: long CSCO (2% notional) and short CMCSA (1.5% notional) for 1–3 months to play relative valuation (CSCO buy-range vs CMCSA at ~86% of target); tighten pair if spread narrows <5% or widens >15%.
• Initiate a speculative 0.5% long in OPEN via 12–18 month deep-OTM calls (or buy LEAPs) given >400% gap to analyst target; cap loss at full premium and review if company issues a financing or guidance change within 90 days.